Date Published
Country
Source
Videos
- Reset All Filters
- 26 results found
- x United States
- x @CNBC
- x @SkyNews
- x COVID-19
-
Regeneron Antibody Drug Shown to Prevent Symptomatic Covid-19
Regeneron reported Tuesday that its antibody cocktail for coronavirus has show a reduction in overall infections seen within the first week, with 100% prevention of symptomatic infections. -
Johnson & Johnson Covid-19 Vaccine Study Paused Due to Unexplained Illness in Participant
The study of Johnson & Johnson's Covid-19 vaccine has been paused due to an unexplained illness in a study participant.Comments
No comments yet. Create an account and log in to post a comment.
-
COVID-19 Vaccine a ‘Political Football’ in United States
The coronavirus vaccine has become a political football in the United States, which is part of why surveys show half of Americans would choose not to take a vaccine for COVID-19 were it made available.Comments
No comments yet. Create an account and log in to post a comment.
-
Dr. Anthony Fauci: Coronavirus will Never Be Eradicated
White House coronavirus advisor Dr. Anthony Fauci said Wednesday it is unlikely the coronavirus will ever be eradicated.Comments
No comments yet. Create an account and log in to post a comment.
-
Additional Remdesivir Data Shows Improved Recovery
The data shows the treatment reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone.Comments
No comments yet. Create an account and log in to post a comment.
-
U.S. Coronavirus Cases Near 3 million after the Country Reported a Record Single-Day Increase
The United States reported more than 60,000 new Covid-19 cases on Tuesday, setting a fresh record for new cases reported in a single day, according to data compiled by Johns Hopkins University.Comments
No comments yet. Create an account and log in to post a comment.
-
Regeneron Receives $450 Million Federal Contract for Covid-19 Antibody Drug
The U.S. government has provided Regeneron with $450 million contract to supply and manufacture its Covid-19 anti-viral antibody cocktail.Comments
No comments yet. Create an account and log in to post a comment.
-
Moderna Covid-19 Vaccine Trial Delayed, July Start Still Possible
Moderna’s stock fell 8% on Thursday after a report said the biotech company’s late-stage trial for a potential coronavirus vaccine will be delayed.Comments
No comments yet. Create an account and log in to post a comment.
-
Dexamethasone Demand Surges Following Promising Covid-19 Treatment Results
Demand is soaring for a cheap and widely used steroid that has been hailed as a potential breakthrough in the treatment of patients with severe Covid-19.Comments
No comments yet. Create an account and log in to post a comment.
-
Persistent Covid-19 Spread is Likely Until We have Vaccine: Former FDA Commissioner
Former FDA Commissioner Dr. Scott Gottlieb on the latest developments in the coronavirus pandemic.Comments
No comments yet. Create an account and log in to post a comment.
-
Eli Lilly Launches First Human Trial of a New Type of Treatment
Eli Lilly has begun dosing the first patients in the phase one study of its potential antibody treatment for Covid-19, the pharmaceutical company announced.Comments
No comments yet. Create an account and log in to post a comment.
-
Can PPE Be Cleaned And Reused?
Due to a PPE shortage during the coronavirus crisis, the CDC and FDA are allowing for sanitation and reuse of PPE.Comments
No comments yet. Create an account and log in to post a comment.
-
Dr. Fauci: Many Covid-19 Vaccine Candidates in the Works
CNBC's Meg Tirrell talks with White House advisor Dr. Anthony Fauci about the coronavirus vaccine trials, reopening the economy and more.Comments
No comments yet. Create an account and log in to post a comment.
-
U.S. Government to Control Distribution of Remdesivir, Raising Geopolitical Concerns
Just days after the FDA approved emergency use of Gilead's remdesivir to treat Covid-19, the company says it's donating its entire supply to the government.Comments
No comments yet. Create an account and log in to post a comment.
-
Gilead's Moving Quickly with FDA for Approval of Coronavirus Drug Remdesivir: CEO
Gilead Sciences, the maker of the experimental coronavirus drug remdesivir, is giving investors more details.Comments
No comments yet. Create an account and log in to post a comment.
Comments